Medication info
Pitaaba Tablet (Pitavastatin, Fenofibrate)

Pitaaba Tablet (Pitavastatin, Fenofibrate)

Prescription medicationTablet경구
Ingredient · strength
Fenofibrate Micronized›160mg / 1 tabletPitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
(주)에이프로젠바이오로직스
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202502259 · Approved 2025.08.28 · Insurance code 645211090

Summary

Main use
Control of LDL cholesterol and improvement of dyslipidemia
Who takes it
Adults
Adult dose
As a recommended dosage, take 1 tablet once daily immediately after a meal.

Ingredients

Manufacturer
(주)에이프로젠바이오로직스

Efficacy & effects

Control of LDL cholesterol and improvement of dyslipidemia

  • Coronary artery disease
  • abnormal LDL cholesterol levels
  • increased triglyceride levels
  • decreased HDL cholesterol levels
  • mixed dyslipidemia
View approved original text

This medication is used to appropriately control LDL cholesterol levels in adult patients at high risk for coronary artery disease and for the treatment of mixed dyslipidemia. It works effectively even when triglyceride levels are high and HDL cholesterol levels are low. This helps reduce the risk of cardiovascular diseases and maintain a healthy blood lipid profile. It aids in safe and effective management according to the patient's treatment goals.

How to take

Adult dose

As a recommended dosage, take 1 tablet once daily immediately after a meal.

Precautions

This medication can affect the muscles, so if symptoms such as muscle pain, muscle weakness, or muscle cramps occur, consult a doctor immediately. Particular caution is required for the elderly, women, patients with poor kidney function, patients with uncontrolled hypothyroidism, patients with a history of muscle diseases, and patients with alcohol abuse. This medication may increase the risk of muscle damage when taken with other lipid-lowering agents or specific medications, so always consult a doctor regarding co-administration. Patients with poor liver function or liver disease, gallbladder disease, or pancreatitis should not use this medication. Patients with moderate to severe renal impairment should not be administered this drug, and those with mild renal impairment should use it cautiously. Women who are pregnant or may become pregnant, nursing mothers, and children under 18 years of age should not take this medication. Patients with blood coagulation disorders or those taking anticoagulants should exercise caution due to the risk of bleeding. Regular blood tests and liver function tests should be conducted during the treatment, and any abnormal symptoms should be reported to medical personnel immediately. Dizziness may occur when driving or operating machinery, so caution is advised. In case of overdose, there is no specific antidote, so appropriate treatment should be administered based on symptoms. It is advisable to take this medication with food, and store it in its original container out of the reach of children.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor (severe allergic reaction), severe rash with high fever, blisters, pain of oral/ocular mucosa (severe skin response), difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever (respiratory problems), yellowing of skin or eyes (jaundice), extreme lethargy (liver abnormalities), sudden and severe

Mild side effects

Pharyngitis, upper respiratory tract infection, dizziness, headache, hypertension, chronic gastritis, erosive gastritis, gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea, bloating), thirst, dyspepsia, constipation, stomatitis, loss of appetite, glossitis, nausea, gastrointestinal discomfort, thrombocytopenia, increased hematuria, palpitations, fatigue, skin pain, burning sensation, joint pain, swelling, blurred vision, photophobia, hearing loss, urine hematuria, increased uric acid levels, elevated serum potassium and phosphorus levels, minor

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness over time.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.